Epithelial cell adhesion molecules (EpCAM) CD133, EGFR, and HER2 are additional targets overexpressed in cancer cells, cancer stem cells, and/or tumor endothelial cells, which have been exploited in the design of aptamer-functionalized nanoparticles. This evidence concerns the gene EGFR and neoplasm.